Physicochemical, Thermal, and Spectroscopic Characterization of the Consciousness Energy Healing Treated Cholecalciferol

Physicochemical, Thermal, and Spectroscopic Characterization of the Consciousness Energy Healing Treated Cholecalciferol

Materials Science, Vitamins

Cholecalciferol (Vitamin D3) is used in the nutraceuticals for the prevention and treatment of vitamin D deficiency. This study was performed to determine the impact of The Trivedi Effect®-Consciousness Energy Healing Treatment on the physicochemical, thermal, and spectral properties of cholecalciferol using modern analytical techniques. Cholecalciferol was divided into two parts and termed as a control and treated sample. The treated part only received the Trivedi Effect®-Consciousness Energy Healing Treatment remotely by the famous Biofield Energy Healer, Mr. Mahendra Kumar Trivedi. The powder X-ray diffraction data revealed that the relative peak intensities and the crystallite size of the treated sample were significantly altered ranging from -58.97% to 25.95% and -55.52% to 53.84%, respectively, along with 23.32% decrease in the average crystallite size compared to the control sample. The latent heat of fusion and latent heat of decomposition of the Biofield Energy Treated cholecalciferol were decreased by 4.21% and 4.51%, respectively compared to the control sample. Besides, the particle size values of treated sample were significantly increased by 659.11% (d10), 594.44% (d50), 509.83% (d90), and 570.55% {D(4,3)}, respectively compared to the control sample. Therefore, the specific surface area of the treated cholecalciferol was significantly reduced by 81.67% compared to the control sample. Thus, it was anticipated that the Trivedi Effect® might have produced the novel polymorphs of cholecalciferol via the possible mediation of neutrinos that could be helpful in improving the shape, size, appearance, and powder flow ability. Thus, the Biofield Energy Treated cholecalciferol could be useful in designing more efficacious nutraceutical and pharmaceutical formulations that may have improved therapeutic response against vitamin D deficiency and associated diseases such as, osteoporosis, rickets, cancer, etc.

Mahendra Kumar Trivedi and Snehasis Jana

Academic Strive

May 10, 2019

[no text]

[no text]

[no text]

[no text]

English

Journal Article

[no text]

[no text]